Publications

Articles publiés par les experts du Réseau Amylose

Consultez les articles publiés par les experts du Réseau Amylose. le numéro PMID vous permet de retrouver l’article et le lien pubmed de le consulter en ligne.
Pour retrouver un article dans ce tableau, sélectionnez sur votre clavier “ctrl + F” et tapez des mots clés de l’article ou son numéro PMID.
Ce tableau, mis à jour chaque année, répertorie les articles du site PUBMED.
Pour compléter ce tableau, nous avons intégré dans le moteur de recherche “Nom de l’expert première lettre du prénom and cardiac amyloidosis” exemple : “lairez o and cardiac amyloidosis”
PMIDTitleAuthorsCitationFirst Authorlien PUBMED
35747521Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac AmyloidosisGuendouz S, Grimbert P, Radu C, Cherqui D, Salloum C, Mongardon N, Maghrebi S, Belhadj K, Le Bras F, Teiger E, Couetil JP, Balan A, Kharoubi M, Bézard M, Oghina S, Bodez D, Hittinger L, Audard V, Planté-Bordeneuve V, De la Taille A, Bergoend E, Frenkel V, Fanen P, Leroy V, Duvoux C, Carmagnat M, Folliguet T, Damy T.Transplant Direct 2022 Jun 17https://pubmed.ncbi.nlm.nih.gov/35747521/
35734274Diagnostic and Prognostic Values of Cardiopulmonary Exercise Testing in Cardiac AmyloidosisBanydeen R, Monfort A, Inamo J, Neviere R.Front Cardiovasc Med 2022 Jun 6https://pubmed.ncbi.nlm.nih.gov/35734274/
35717381Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year updateDispenzieri A, Coelho T, Conceição I, Waddington-Cruz M, Wixner J, Kristen AV, Rapezzi C, Planté-Bordeneuve V, Gonzalez-Moreno J, Maurer MS, Grogan M, Chapman D, Amass LOrphanet J Rare Dis2022 junhttps://pubmed.ncbi.nlm.nih.gov/35717381/
35665045Cerebral Ischemic Events: An Overlooked Complication of Transthyretin Cardiac Amyloidosis in Afro-Caribbean PatientsBanydeen R, Signate A, Tran TH, Monfort A, Neviere R, Inamo J.Front Neurol 2022 May 19https://pubmed.ncbi.nlm.nih.gov/35665045/
35652845Amylose cardiaque dite sénile : diagnostic et nouvelles perspectives thérapeutiquesBerrut G, Piriou N, Boureau AS, Hanon O, Trochu JN.Geriatr Psychol Neuropsychiatr Vieil 2022 Mar 1https://pubmed.ncbi.nlm.nih.gov/35652845/
35608040Characteristics and natural history of early-stage cardiac transthyretin amyloidosisLaw S, Bezard M, Petrie A, Chacko L, Cohen OC, Ravichandran S, Ogunbiyi O, Kharoubi M, Ganeshananthan S, Ganeshananthan S, Gilbertson JA, Rowczenio D, Wechalekar A, Martinez-Naharro A, Lachmann HJ, Whelan CJ, Hutt DF, Hawkins PN, Damy T, Fontana M, Gillmore JD.Eur Heart J2022 May 24https://pubmed.ncbi.nlm.nih.gov/35608040/
35583798Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Campbell CM, LoRusso S, Dispenzieri A, Kristen AV, Maurer MS, Rapezzi C, Lairez O, Drachman B, Garcia-Pavia P, Grogan M, Chapman D, Amass LCardiol Ther2022 Mayhttps://pubmed.ncbi.nlm.nih.gov/35583798/
35346209Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patientsMonfort A, Rivas A, Banydeen R, Inamo J, Farid K, Neviere R.Respir Res2022 Mar 27https://pubmed.ncbi.nlm.nih.gov/35346209/
35184821Cardiac imaging in infiltrative cardiomyopathies. What cardiovascular imaging modalities to propose in hypertrophic cardiomyopathies ?Pasteur-Rousseau A, Odouard S, Souibri K, Sebag FA, Deux JF, Damy T.Ann Cardiol Angeiol (Paris)2022 Aprhttps://pubmed.ncbi.nlm.nih.gov/35184821/
35144512Amyloidosis from the patient perspective: the French daily impact of amyloidosis studyDamy T, Adams D, Bridoux F, Grateau G, Planté-Bordeneuve V, Ghiron Y, Farrugia A, Pelcot F, Taieb C, Labeyrie C, Jaccard A, Georgin-Lavialle S.Amyloid2022 Febhttps://pubmed.ncbi.nlm.nih.gov/35144512/
35128833Prevalence and determinants of iron deficiency in cardiac amyloidosisJobbé-Duval A, Bézard M, Moutereau S, Kharoubi M, Oghina S, Zaroui A, Galat A, Chalard C, Hugon-Vallet E, Lemonnier F, Eyharts D, Poulot E, Fanen P, Funalot B, Molinier-Frenkel V, Audard V, Hittinger L, Delbarre MA, Teiger E, Damy T.ESC Heart Fail 2022 Aprhttps://pubmed.ncbi.nlm.nih.gov/35128833/
35114877Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survivalKharoubi M, Bodez D, Bézard M, Zaroui A, Galat A, Guendouz S, Gendre T, Hittinger L, Attias D, Mohty D, Bergoend E, Itti E, Lebras F, Hamon D, Poullot E, Molinier-Frenkel V, Lellouche N, Deux JF, Funalot B, Fannen P, Oghina S, Arrouasse R, Lecorvoisier P, Souvannanorath S, Amiot A, Teiger E, Bougouin W, Damy T.Amyloid2022 Junhttps://pubmed.ncbi.nlm.nih.gov/35114877/
34996829Restrictive spirometry pattern and abnormal cardiopulmonary response to exercise in transthyretin cardiac amyloidosisBanydeen R, Vergaro G, Deney A, Monfort A, Emdin M, Lairez O, Giguet AG, Inamo J, Neviere R.Eur Respir J2022 Feb 24https://pubmed.ncbi.nlm.nih.gov/34996829/
34917658New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic ImpactCariou E, Sanchis K, Rguez K, Blanchard V, Cazalbou S, Fournier P, Huart A, Roussel M, Cintas P, Galinier M, Carrié D, Maury P, Lavie-Badie Y, Lairez O.Front Cardiovasc Med2021 Nov 30https://pubmed.ncbi.nlm.nih.gov/34917658/
34841715(99m) Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathyTahara N, Lairez O, Endo J, Okada A, Ueda M, Ishii T, Kitano Y, Lee HE, Russo E, Kubo T.ESC Heart Fail2022 Febhttps://pubmed.ncbi.nlm.nih.gov/34841715/
34823661Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering AnalysisBonnefous L, Kharoubi M, Bézard M, Oghina S, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Deux JF, Audard V, Itti E, Damy T, Audureau E.J Am Coll Cardiol2021 Nov 30https://pubmed.ncbi.nlm.nih.gov/34823661/
34784656Thromboembolism and bleeding in systemic amyloidosis: a reviewNicol M, Siguret V, Vergaro G, Aimo A, Emdin M, Dillinger JG, Baudet M, Cohen-Solal A, Villesuzanne C, Harel S, Royer B, Arnulf B, Logeart D.ESC Heart Fail2022 Febhttps://pubmed.ncbi.nlm.nih.gov/34784656/
34779246Tafamidis and quality of life in people with transthyretin amyloid cardiomyopathy in the study ATTR-ACT: A plain language summaryHanna M, Damy T, Grogan M, Stewart M, Gundapaneni B, Sultan MB, Maurer MS.Future Cardiol2022 Marhttps://pubmed.ncbi.nlm.nih.gov/34779246/
34768408Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated EvaluationOghina S, Bougouin W, Kharoubi M, Bonnefous L, Galat A, Guendouz S, Bezard M, Le Bras F, Deux JF, Itti E, Moktefi A, Fanen P, Teiger E, Mohty D, Damy T, Bodez D.J Clin Med2021 Oct 23https://pubmed.ncbi.nlm.nih.gov/34768408/
34768388Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis TreatmentOghina S, Josse C, Bézard M, Kharoubi M, Delbarre MA, Eyharts D, Zaroui A, Guendouz S, Galat A, Hittinger L, Fanen P, Teiger E, Mouri N, Montestruc F, Damy T.J Clin Med2021 Oct 22https://pubmed.ncbi.nlm.nih.gov/34768388/
34734471Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosisFischer K, Lellouche N, Damy T, Martins R, Clementy N, Bisson A, Lesaffre F, Espinosa M, Garcia R, Degand B, Serzian G, Jourda F, Huttin O, Guichard JB, Devilliers H, Eicher JC, Laurent G, Guenancia C.ESC Heart Fail2022 Febhttps://pubmed.ncbi.nlm.nih.gov/34734471/
34729526Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes SurveyNativi-Nicolau J, Siu A, Dispenzieri A, Maurer MS, Rapezzi C, Kristen AV, Garcia-Pavia P, LoRusso S, Waddington-Cruz M, Lairez O, Witteles R, Chapman D, Amass L, Grogan MJACC CardioOncol2021 Octhttps://pubmed.ncbi.nlm.nih.gov/34729526/
34714605History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosisKharoubi M, Bézard M, Galat A, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Moktefi A, Lefaucheur JP, Abulizi M, Deux JF, Lemonnier F, Guendouz S, Chalard C, Zaroui A, Audard V, Bequignon E, Bodez D, Itti E, Hittinger L, Audureau E, Teiger E, Oghina S, Damy T.ESC Heart Fail2021 Dechttps://pubmed.ncbi.nlm.nih.gov/34714605/
34643339Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosisFagot J, Lavie-Badie Y, Blanchard V, Fournier P, Galinier M, Carrié D, Lairez O, Cariou EESC Heart Fail2021 Febhttps://pubmed.ncbi.nlm.nih.gov/34643339/
34602081Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progressionAdams D, Algalarrondo V, Polydefkis M, Sarswat N, Slama MS, Nativi-Nicolau J.Orphanet J Rare Dis2021 Oct 3https://pubmed.ncbi.nlm.nih.gov/34602081/
34525116Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvementBézard M, Oghina S, Vitiello D, Kharoubi M, Kordeli E, Galat A, Zaroui A, Guendouz S, Gilles F, Shourick J, Hamon D, Audard V, Teiger E, Poullot E, Molinier-Frenkel V, Lemonnier F, Agbulut O, Le Bras F, Damy T.PLoS One2021 Sep 15https://pubmed.ncbi.nlm.nih.gov/34525116/
34490695AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of “monoclonal gammopathy of inflammatory significance”?Terré A, Colombat M, Cez A, Martin C, Diet C, Brechignac S, Oghina S, Bodez D, Faguer S, Savey L, Galland J, Boffa JJ, Grateau G, Jaccard A, Buob D, Georgin-Lavialle S.Int J Clin Pract2021 Novhttps://pubmed.ncbi.nlm.nih.gov/34490695/
34391735Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOSCaponetti AG, Rapezzi C, Gagliardi C, Milandri A, Dispenzieri A, Kristen AV, Wixner J, Maurer MS, Garcia-Pavia P, Tournev I, Planté-Bordeneuve V, Chapman D, Amass LJACC Heart Fail2021 Octhttps://pubmed.ncbi.nlm.nih.gov/34391735/
34362197Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the IcebergBroussier A, David JP, Kharoubi M, Oghina S, Segaux L, Teiger E, Laurent M, Fromentin I, Bastuji-Garin S, Damy T.J Clin Med2021 Jul 31https://pubmed.ncbi.nlm.nih.gov/34362197/
34274113Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidanceSabouret P, Attias D, Beauvais C, Berthelot E, Bouleti C, Gibault Genty G, Galat A, Hanon O, Hulot JS, Isnard R, Jourdain P, Lamblin N, Lebreton G, Lellouche N, Logeart D, Meune C, Pezel T, Damy T.Ann Cardiol Angeiol (Paris)2022 Febhttps://pubmed.ncbi.nlm.nih.gov/34274113/
34230094Adaptive servo ventilation for sleep apnoea in heart failure: the FACE study 3-month dataTamisier R, Damy T, Bailly S, Davy JM, Verbraecken J, Lavergne F, Palot A, Goutorbe F, d’Ortho MP, Pépin JLThorax2022 Febhttps://pubmed.ncbi.nlm.nih.gov/34230094/
34173675First symptoms and health care pathways in hospitalized patients with acute heart failure: ICPS2 survey. A report from the Heart Failure Working Group (GICC) of the French Society of CardiologyBeauvais F, Tartière L, Pezel T, Motet C, Aumont MC, Baudry G, Eicher JC, Galinier M, Gellen B, Guihaire J, Legallois D, Lequeux B, Mika D, Mouquet F, Salvat M, Taieb C, Zorès F, Berthelot E, Damy T.Clin Cardiol 2021 Aughttps://pubmed.ncbi.nlm.nih.gov/34173675/
34100681Diagnostic Value of Extracellular Volume Quantification and Myocardial Perfusion Analysis at CT in Cardiac AmyloidosisDeux JF, Nouri R, Tacher V, Zaroui A, Derbel H, Sifaoui I, Chevance V, Ridouani F, Galat A, Kharoubi M, Oghina S, Guendouz S, Audureau E, Teiger E, Kobeiter H, Damy T.Radiology 2021 Aughttps://pubmed.ncbi.nlm.nih.gov/34100681/
34089308Progress and challenges in the treatment of cardiac amyloidosis: a review of the literatureAdam RD, Coriu D, Jercan A, Bădeliţă S, Popescu BA, Damy T, Jurcuţ R.ESC Heart Fail 2021 Aughttps://pubmed.ncbi.nlm.nih.gov/34089308/
34042016A simple core dataset and disease severity score for hereditary transthyretin (ATTRv) amyloidosisDamy T, Conceição I, García-Pavía P, Gillmore J, Jandhyala R, Sabbat J, Wixner J, Coelho T.Amyloid 2021 Sephttps://pubmed.ncbi.nlm.nih.gov/34042016/
34035264A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cellsMichalon A, Hagenbuch A, Huy C, Varela E, Combaluzier B, Damy T, Suhr OB, Saraiva MJ, Hock C, Nitsch RM, Jan Grimm.Nat Commun 2021 May 25https://pubmed.ncbi.nlm.nih.gov/34035264/
34024024Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Waddington-Cruz M, Wixner J, Amass L, Kiszko J, Chapman D, Ando YNeurol Ther2021 Dechttps://pubmed.ncbi.nlm.nih.gov/34024024/
33980765Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With Aortic StenosisRobin G, Cognet T, Bouisset F, Cariou E, Méjean S, Pradel S, Colombat M, Galinier M, Carrié D, Lairez OCirc J2021 Aughttps://pubmed.ncbi.nlm.nih.gov/33980765/
33957949ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtableBrannagan TH 3rd, Auer-Grumbach M, Berk JL, Briani C, Bril V, Coelho T, Damy T, Dispenzieri A, Drachman BM, Fine N, Gaggin HK, Gertz M, Gillmore JD, Gonzalez E, Hanna M, Hurwitz DR, Khella SL, Maurer MS, Nativi-Nicolau J, Olugemo K, Quintana LF, Rosen AM, Schmidt HH, Shehata J, Waddington-Cruz M, Whelan C, Ruberg FL.Orphanet J Rare Dis 2021 May 6https://pubmed.ncbi.nlm.nih.gov/33957949/
33933023Good performance in the management of acute heart failure in cardiogeriatric departments: the ICREX-94 experienceBerthelot E, Broussier A, Damy T, Donadio C, Cosson S, Rovani X, Salengro E, Billebeau G, Megbemado R, Rekik N, Godreuil C, Richard K, Shourick J, Assayag P, Belmin J, David JP, Hittinger LBMC Geriatr2021 Mayhttps://pubmed.ncbi.nlm.nih.gov/33933023/
33915002Expert consensus on the monitoring of transthyretin amyloid cardiomyopathyGarcia-Pavia P, Bengel F, Brito D, Damy T, Duca F, Dorbala S, Nativi-Nicolau J, Obici L, Rapezzi C, Sekijima Y, Elliott PM.Eur J Heart Fail 2021 Junhttps://pubmed.ncbi.nlm.nih.gov/33915002/
33826207Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesGarcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG, Linhart A.Eur J Heart Fail 2021 Aprhttps://pubmed.ncbi.nlm.nih.gov/33826207/
33825853Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial DiseasesGarcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG, Linhart A.Eur Heart J 2021 Apr 21https://pubmed.ncbi.nlm.nih.gov/33825853/
33713427Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosisPasquer H, Belhadj K, Dupuis J, Oghina S, Galat A, Ladaique A, Maarek A, Roulin L, Gounot R, Poulot E, Beldi-Ferchiou A, Molinier-Frenkel V, Haioun C, Damy T, Le Bras F, Lemonnier F.Br J Haematol 2021 Mayhttps://pubmed.ncbi.nlm.nih.gov/33713427/
33619905Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working GroupPezel T, Audureau E, Mansourati J, Baudry G, Ben Driss A, Durup F, Fertin M, Godreuil C, Jeanneteau J, Kloeckner M, Koukoui F, Kesri-Tartière L, Laperche T, Roubille F, Cohen-Solal A, Damy T.ESC Heart Fail 2021 Aprhttps://pubmed.ncbi.nlm.nih.gov/33619905/
33549560The Impact of Patients With Cardiac Amyloidosis in HFpEF TrialsOghina S, Bougouin W, Bézard M, Kharoubi M, Komajda M, Cohen-Solal A, Mebazaa A, Damy T, Bodez D.JACC Heart Fail 2021 Marhttps://pubmed.ncbi.nlm.nih.gov/33549560/
33441470Tip of the iceberg: a tertiary care centre retrospective study of left ventricular hypertrophy aetiologiesBeneyto M, Cariou E, Brunel J, Scripcariu A, Delasnerie H, Brun S, Lavie-Badie Y, Dupin Deguine D, Galinier M, Carrié D, Lairez O.Open Heart 2021 Janhttps://pubmed.ncbi.nlm.nih.gov/33441470/
33422349Cardiac amyloidosisPoullot E, Oghina S, Kalsoum S, Damy T.Ann Pathol 2021 Febhttps://pubmed.ncbi.nlm.nih.gov/33422349/
33354901Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosisKharoubi M, Roche F, Bézard M, Hupin D, Silva S, Oghina S, Chalard C, Zaroui A, Galat A, Guendouz S, Canoui-Poitrine F, Hittinger L, Teiger E, Lefaucheur JP, Damy T.ESC Heart Fail 2021 Aprhttps://pubmed.ncbi.nlm.nih.gov/33354901/
33340199Reply to the letter regarding the article ‘Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study’Damy T, Sultan MB, Witteles R.Eur J Heart Fail 2021 Junhttps://pubmed.ncbi.nlm.nih.gov/33340199/
33309574Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACTRapezzi C, Elliott P, Damy T, Nativi-Nicolau J, Berk JL, Velazquez EJ, Boman K, Gundapaneni B, Patterson TA, Schwartz JH, Sultan MB, Maurer MS.JACC Heart Fail 2021 Febhttps://pubmed.ncbi.nlm.nih.gov/33309574/
33251891Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairmentGounot R, Le Bras F, Dupuis J, Oghina S, Bodez D, Roulin L, Maarek A, Ladaique A, Beldi-Ferchiou A, Poullot E, Molinier-Frenkel V, Haioun C, Damy T, Belhadj K, Lemonnier F.Leuk Lymphoma 2021 Aprhttps://pubmed.ncbi.nlm.nih.gov/33251891/
33245757New expectations for diastolic function assessment in transthoracic echocardiography based on a semi-automated computing of strain-volume loopsHubert A, Le Rolle V, Galli E, Bidaud A, Hernandez A, Donal E.Eur Heart J Cardiovasc Imaging 2020 Dec 1https://pubmed.ncbi.nlm.nih.gov/33245757/
33220323Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)Hanna M, Damy T, Grogan M, Stewart M, Gundapaneni B, Patterson TA, Schwartz JH, Sultan MB, Maurer MS.Am J Cardiol 2021 Feb 15https://pubmed.ncbi.nlm.nih.gov/33220323/
33212063Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension studyAdams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho TLancet Neurol2021 Janhttps://pubmed.ncbi.nlm.nih.gov/33212063/
33094885Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosisBézard M, Kharoubi M, Galat A, Poullot E, Guendouz S, Fanen P, Funalot B, Moktefi A, Lefaucheur JP, Abulizi M, Deux JF, Gendre T, Audard V, El Karoui K, Canoui-Poitrine F, Zaroui A, Itti E, Teiger E, Planté-Bordeneuve V, Oghina S, Damy T.Eur J Heart Fail 2021 Febhttps://pubmed.ncbi.nlm.nih.gov/33094885/
33070419Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension studyDamy T, Garcia-Pavia P, Hanna M, Judge DP, Merlini G, Gundapaneni B, Patterson TA, Riley S, Schwartz JH, Sultan MB, Witteles R.Eur J Heart Fail 2021 Febhttps://pubmed.ncbi.nlm.nih.gov/33070419/
33067004[Diagnosing cardiac amyloidosis in magnetic resonance imaging: The discriminating factors]Goïorani F, Dagrenat C, Brocchi J, Couppie P, Leddet P.Ann Cardiol Angeiol (Paris) 2020 Novhttps://pubmed.ncbi.nlm.nih.gov/33067004/
33051335Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?Roger-Rollé A, Cariou E, Rguez K, Fournier P, Lavie-Badie Y, Blanchard V, Roncalli J, Galinier M, Carrié D, Lairez OOpen Heart2020 Octhttps://pubmed.ncbi.nlm.nih.gov/33051335/
33006180Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosisNicol M, Deney A, Lairez O, Vergaro G, Emdin M, Carecci A, Inamo J, Montfort A, Neviere R, Damy T, Harel S, Royer B, Baudet M, Cohen-Solal A, Arnulf B, Logeart D.Eur J Heart Fail 2021 Febhttps://pubmed.ncbi.nlm.nih.gov/33006180/
32967612Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitionerGertz M, Adams D, Ando Y, Beirão JM, Bokhari S, Coelho T, Comenzo RL, Damy T, Dorbala S, Drachman BM, Fontana M, Gillmore JD, Grogan M, Hawkins PN, Lousada I, Kristen AV, Ruberg FL, Suhr OB, Maurer MS, Nativi-Nicolau J, Quarta CC, Rapezzi C, Witteles R, Merlini G.BMC Fam Pract 2020 Sep 23https://pubmed.ncbi.nlm.nih.gov/32967612/
32826087Transthyretin cardiac amyloidosisEicher JC, Audia S, Damy T.Rev Med Interne 2020 Octhttps://pubmed.ncbi.nlm.nih.gov/32826087/
32738048Aortic stenosis and amyloid heart disease: ‘the 2A dangerous liaisons’Mohty D, Pibarot P, Damy T.Eur Heart J 2020 Aug 1https://pubmed.ncbi.nlm.nih.gov/32738048/
32617488Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapyAouate D, Menet A, Bellevre D, Damy T, Marechaux S.Eur Heart J Case Rep 2020 May 1https://pubmed.ncbi.nlm.nih.gov/32617488/
32588554Gateway and journey of patients with cardiac amyloidosisDang D, Fournier P, Cariou E, Huart A, Ribes D, Cintas P, Roussel M, Colombat M, Lavie-Badie Y, Carrié D, Galinier M, Lairez O.ESC Heart Fail 2020 Octhttps://pubmed.ncbi.nlm.nih.gov/32588554/
32456532DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosisAkinboboye O, Shah K, Warner AL, Damy T, Taylor HA, Gollob J, Powell C, Karsten V, Vest J, Maurer MS.Amyloid 2020 Dechttps://pubmed.ncbi.nlm.nih.gov/32456532/
32405988(99m)Tc-labelled bone tracer myocardial quantification: About correlation with heart functionBlondet C, Schaeffer O, Hubelé F, Roul GJ, Imperiale A, Namer IJ.J Nucl Cardiol 2020 Aughttps://pubmed.ncbi.nlm.nih.gov/32405988/
32385539Characterization of Fabry Disease cardiac involvement according to longitudinal strain, cardiometabolic exercise test, and T1 mappingRéant P, Testet E, Reynaud A, Bourque C, Michaud M, Rooryck C, Goizet C, Lacombe D, de-Précigout V, Peyrou J, Cochet H, Lafitte S.Int J Cardiovasc Imaging 2020 Julhttps://pubmed.ncbi.nlm.nih.gov/32385539/
32157431Extracardiac soft tissue uptake, evidenced on early (99m)Tc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic valueMalka N, Abulizi M, Kharoubi M, Oghina S, Galat A, Le Bras F, Moktefi A, Guendouz S, Molinier-Frenkel V, Fanen P, Funalot B, Lefaucheur JP, Blanc-Durand P, Deux JF, Audard V, Bodez D, Itti E, Damy T.Eur J Nucl Med Mol Imaging 2020 Sephttps://pubmed.ncbi.nlm.nih.gov/32157431/
32036861CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in AmyloidosisO’Meara E, McDonald M, Chan M, Ducharme A, Ezekowitz JA, Giannetti N, Grzeslo A, Heckman GA, Howlett JG, Koshman SL, Lepage S, Mielniczuk LM, Moe GW, Swiggum E, Toma M, Virani SA, Zieroth S, De S, Matteau S, Parent MC, Asgar AW, Cohen G, Fine N, Davis M, Verma S, Cherney D, Abrams H, Al-Hesayen A, Cohen-Solal A, D’Astous M, Delgado DH, Desplantie O, Estrella-Holder E, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Lee D, Masoudi FA, McKelvie RS, Rajda M, Ross HJ, Sussex B.Can J Cardiol 2020 Febhttps://pubmed.ncbi.nlm.nih.gov/32036861/
32024385Restrictive cardiac phenotype as primary cause of impaired aerobic capacity in Afro-Caribbean patients with val122ile variant transthyretin amyloid cardiomyopathyMonfort A, Banydeen R, Demoniere F, Courty B, Codiat R, Neviere R, Inamo J.Amyloid 2020 Sephttps://pubmed.ncbi.nlm.nih.gov/32024385/
32007555Echocardiographic Evaluation of Left Ventricular Filling Pressure in Patients With Heart Failure With Preserved Ejection Fraction: Usefulness of Inferior Vena Cava Measurements and 2016 EACVI/ASE RecommendationsBerthelot E, Jourdain P, Bailly MT, Bouchachi A, Gellen B, Rouquette A, Damy T, Hervé P, Chemla D, Assayag P.J Card Fail 2020 Junhttps://pubmed.ncbi.nlm.nih.gov/32007555/
31949094Conjunctival lymphangiectasia as a biomarker of severe systemic disease in Ser77Tyr hereditary transthyretin amyloidosisBunod R, Adams D, Cauquil C, Francou B, Labeyrie C, Bourenane H, Adam C, Algalarrondo V, Slama M, Darce-Bello M, Barreau E, Labetoulle M, Rousseau A.Br J Ophthalmol 2020 Octhttps://pubmed.ncbi.nlm.nih.gov/31949094/
31873816Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosisManrique A, Dudoignon D, Brun S, N’Ganoa C, Cassol E, Legallois D, Lavie-Badie Y, Agostini D, Lairez O.EJNMMI Res 2019 Dec 23https://pubmed.ncbi.nlm.nih.gov/31873816/
31753206Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the WeekTernacle J, Krapf L, Mohty D, Magne J, Nguyen A, Galat A, Gallet R, Teiger E, Côté N, Clavel MA, Tournoux F, Pibarot P, Damy T.J Am Coll Cardiol 2019 Nov 26https://pubmed.ncbi.nlm.nih.gov/31753206/
31512197(18)F-sodium fluoride PET/MRI myocardial imaging in patients with suspected cardiac amyloidosisAbulizi M, Sifaoui I, Wuliya-Gariepy M, Kharoubi M, Israël JM, Emsen B, Bodez D, Monnet A, Didierlaurent D, Tacher V, Luciani A, Damy T, Deux JF, Itti E.J Nucl Cardiol 2021 Aughttps://pubmed.ncbi.nlm.nih.gov/31512197/
31502881Association between hearing loss and hereditary ATTR amyloidosisBartier S, Bodez D, Kharoubi M, Guellich A, Canouï-Poitrine F, Chatelin V, Coste A, Damy T, Béquignon E.Amyloid 2019 Dechttps://pubmed.ncbi.nlm.nih.gov/31502881/
31480867Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac AmyloidosisMaurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J, Cristina Quarta C, Rapezzi C, Ruberg FL, Witteles R, Merlini G.Circ Heart Fail 2019 Sephttps://pubmed.ncbi.nlm.nih.gov/31480867/
31364411Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational studyBartier S, Bodez D, Kharoubi M, Canouï-Poitrine F, Chatelin V, Henrion C, Coste A, Damy T, Béquignon E.Amyloid 2019 Dechttps://pubmed.ncbi.nlm.nih.gov/31364411/
31302046Screening for Transthyretin Amyloid Cardiomyopathy in Everyday PracticeWitteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, Gospodinova M, Obici L, Rapezzi C, Garcia-Pavia P.JACC Heart Fail 2019 Aughttps://pubmed.ncbi.nlm.nih.gov/31302046/
31292624Diagnostic score of cardiac involvement in AL amyloidosisNicol M, Baudet M, Brun S, Harel S, Royer B, Vignon M, Lairez O, Lavergne D, Jaccard A, Attias D, Macron L, Gayat E, Cohen-Solal A, Arnulf B, Logeart D.Eur Heart J Cardiovasc Imaging 2020 May 1https://pubmed.ncbi.nlm.nih.gov/31292624/
31217996Value of natriuretic peptides and tissue Doppler imaging in the estimation of left ventricular filling pressure in patients with cardiac amyloidosisBrun S, Cariou E, Fournier P, Ribes D, Faguer S, Huart A, Carrié D, Galinier M, Lairez OOpen Heart2019 Mayhttps://pubmed.ncbi.nlm.nih.gov/31217996/
31183088Light chain lambda myeloma with fatal AL cardiac amyloidosis in a 21-year-old patient: A case report and reviewCamus V, Dubois S, Thiébaut PA, Lepretre S, Lenain P, Picquenot JM, Veresezan EL, François A, Penther D, Bauer F, Jaccard A, Jardin F.Clin Case Rep 2019 May 7https://pubmed.ncbi.nlm.nih.gov/31183088/
31172799Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortalitySanchis K, Cariou E, Colombat M, Ribes D, Huart A, Cintas P, Fournier P, Rollin A, Carrié D, Galinier M, Maury P, Duparc A, Lairez OAmyloid2019 septhttps://pubmed.ncbi.nlm.nih.gov/31172799/
31103217Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac AmyloidosisDang J, Abulizi M, Moktefi A, El Karoui K, Deux JF, Bodez D, Le Bras F, Belhadj K, Remy P, Issaurat P, Plante-Bordeneuve V, Molinier-Frenkel V, Fanen P, Guendouz S, Kharoubi M, Itti E, Damy T, Audard V.Mayo Clin Proc 2019 Junhttps://pubmed.ncbi.nlm.nih.gov/31103217/
30938420Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)Damy T, Kristen AV, Suhr OB, Maurer MS, Planté-Bordeneuve V, Yu CR, Ong ML, Coelho T, Rapezzi CRadiologie2021 aouthttps://pubmed.ncbi.nlm.nih.gov/30938420/
30793974Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutationsConceição I, Damy T, Romero M, Galán L, Attarian S, Luigetti M, Sadeh M, Sarafov S, Tournev I, Ueda M.Amyloid 2019 Marhttps://pubmed.ncbi.nlm.nih.gov/30793974/
30739754[Hypertrophic cardiomyopathies]Lairez O.Rev Med Interne 2019 Junhttps://pubmed.ncbi.nlm.nih.gov/30739754/
30710407Commentary to “A 44-year-old female with familial Mediterranean fever, cardiomyopathy and end stage renal disease” by Magaki et alBodez D, Georgin-Lavialle S, Grateau G, Buob D.Brain Pathol 2019 Marhttps://pubmed.ncbi.nlm.nih.gov/30710407/
30632809Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathyAlgalarrondo V, Antonini T, Théaudin M, Chemla D, Benmalek A, Castaing D, Cauquil C, Rouzet F, Mika D, Duong E, Dinanian S, Eliahou L, Le Guludec D, Samuel D, Adams D, Slama MS.Amyloid 2018 Dechttps://pubmed.ncbi.nlm.nih.gov/30632809/
30623354Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic studyPradel S, Magne J, Jaccard A, Fadel BM, Boulogne C, Salemi VMC, Damy T, Aboyans V, Mohty D.Int J Cardiovasc Imaging 2019 Mayhttps://pubmed.ncbi.nlm.nih.gov/30623354/
30586695Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated AmyloidosisSolomon SD, Adams D, Kristen A, Grogan M, González-Duarte A, Maurer MS, Merlini G, Damy T, Slama MS, Brannagan TH 3rd, Dispenzieri A, Berk JL, Shah AM, Garg P, Vaishnaw A, Karsten V, Chen J, Gollob J, Vest J, Suhr O.Circulation 2019 Jan 22https://pubmed.ncbi.nlm.nih.gov/30586695/
30145929Tafamidis Treatment for Patients with Transthyretin Amyloid CardiomyopathyMaurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi CN Engl J Med2018 Septhttps://pubmed.ncbi.nlm.nih.gov/30145929/
30122209Author’s replyMohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, El Hamel C, Lavergne D, Damy T, Aboyans V, Jaccard A.J Cardiol 2018 Octhttps://pubmed.ncbi.nlm.nih.gov/30122209/
30115079Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosisRidouani F, Damy T, Tacher V, Derbel H, Legou F, Sifaoui I, Audureau E, Bodez D, Rahmouni A, Deux JF.J Cardiovasc Magn Reson 2018 Aug 16https://pubmed.ncbi.nlm.nih.gov/30115079/
30072291Quantification of Myocardial Enhancement on Cine-MRI: Diagnostic Value in Cardiac AmyloidosisCholet C, Damy T, Legou F, Kobeiter H, Rahmouni A, Deux JF.Acad Radiol 2019 Junhttps://pubmed.ncbi.nlm.nih.gov/30072291/
30030912Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issuesBerthelot E, Bauer F, Eicher JC, Flécher E, Gellen B, Guihaire J, Guijarro D, Roul G, Salvat M, Tribouilloy C, Zores F, Lamblin N, de Groote P, Damy T.ESC Heart Fail 2018 Octhttps://pubmed.ncbi.nlm.nih.gov/30030912/
29881913Pattern of myocardial (99m)Tc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosisPradel S, Brun S, Victor G, Pascal P, Fournier P, Ribes D, Lavie-Badie Y, Galinier M, Carrié D, Berry I, Lairez O  https://pubmed.ncbi.nlm.nih.gov/29881913/
29709420Outcome of patients with cardiac amyloidosis admitted to an intensive care unit for acute heart failured’Humières T, Fard D, Damy T, Roubille F, Galat A, Doan HL, Oliver L, Dubois-Randé JL, Squara P, Lim P, Ternacle J.Arch Cardiovasc Dis 2018 Octhttps://pubmed.ncbi.nlm.nih.gov/29709420/
29574587Can Nuclear Imaging Techniques Predict Patient Outcome and Guide Medical Management in Hereditary Transthyretin Cardiac Amyloidosis?Algalarrondo V, Piekarski E, Eliahou L, Le Guludec D, Slama MS, Rouzet F.Curr Cardiol Rep 2018 Mar 24https://pubmed.ncbi.nlm.nih.gov/29574587/
29511839Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriersPiekarski E, Chequer R, Algalarrondo V, Eliahou L, Mahida B, Vigne J, Adams D, Slama MS, Le Guludec D, Rouzet F.Eur J Nucl Med Mol Imaging2018 Julhttps://pubmed.ncbi.nlm.nih.gov/29511839/
29260587Right ventricular longitudinal strain: a tool for diagnosis and prognosis in light-chain amyloidosisUzan C, Lairez O, Raud-Raynier P, Garcia R, Degand B, Christiaens LP, Rehman MB.Amyloid 2018 Marhttps://pubmed.ncbi.nlm.nih.gov/29260587/
29153741Left atrial function in patients with light chain amyloidosis: A transthoracic 3D speckle tracking imaging studyMohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, El Hamel C, Lavergne D, Damy T, Aboyans V, Jaccard A.J Cardiol 2018 Aprhttps://pubmed.ncbi.nlm.nih.gov/29153741/
29048471A new staging system for cardiac transthyretin amyloidosisGillmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A, Quarta CC, Rezk T, Whelan CJ, Gonzalez-Lopez E, Lane T, Gilbertson JA, Rowczenio D, Petrie A, Hawkins PN.Eur Heart J 2018 Aug 7https://pubmed.ncbi.nlm.nih.gov/29048471/
28812126Myocardial iodine concentration measurement using dual-energy computed tomography for the diagnosis of cardiac amyloidosis: a pilot studyChevance V, Damy T, Tacher V, Legou F, Ridouani F, Luciani A, Kobeiter H, Rahmouni A, Deux JF.Eur Radiol 2018 Febhttps://pubmed.ncbi.nlm.nih.gov/28812126/
28598686How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot studyBéquignon E, Guellich A, Bartier S, Raynal M, Prulière-Escabasse V, Canouï-Poitrine F, Coste A, Damy T.Amyloid 2017 Junhttps://pubmed.ncbi.nlm.nih.gov/28598686/
28553897Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosisCariou E, Bennani Smires Y, Victor G, Robin G, Ribes D, Pascal P, Petermann A, Fournier P, Faguer S, Roncalli J, Rousseau H, Chauveau D, Carrié D, Berry I, Galinier M, Lairez OAmyloid2017 juinhttps://pubmed.ncbi.nlm.nih.gov/28553897/
28447284Apical sparing pattern of left ventricular myocardial (99m)Tc-HMDP uptake in patients with transthyretin cardiac amyloidosisVan Der Gucht A, Cottereau AS, Abulizi M, Guellich A, Blanc-Durand P, Israel JM, Galat A, Plante-Bordeneuve V, Dubois-Randé JL, Bodez D, Rosso J, Damy T, Itti E.J Nucl Cardiol 2018 Dechttps://pubmed.ncbi.nlm.nih.gov/28447284/
28384285Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)Kristen AV, Maurer MS, Rapezzi C, Mundayat R, Suhr OB, Damy TPlos One2017 Avrilhttps://pubmed.ncbi.nlm.nih.gov/28384285/
28334621Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosisLe Bras F, Molinier-Frenkel V, Guellich A, Dupuis J, Belhadj K, Guendouz S, Ayad K, Colombat M, Benhaiem N, Tissot CM, Hulin A, Jaccard A, Damy T.Eur J Cancer 2017 Mayhttps://pubmed.ncbi.nlm.nih.gov/28334621/
28219562Isolated Pericardial Infiltration Without Myocardial Involvement in Light-Chain-Related AmyloidosisGeorgin-Lavialle S, Guellich A, Deux JF, Buob D, Damy T.Ann Thorac Surg 2017 Marhttps://pubmed.ncbi.nlm.nih.gov/28219562/
28082242New guidelines, new recommendations! But what is really new? A pragmatic interpretation of the 2016 European guidelines for the management of chronic heart failurede Groote P, Cohen A, Juillière Y, Damy T.Arch Cardiovasc Dis 2017 Janhttps://pubmed.ncbi.nlm.nih.gov/28082242/
27933393Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosisMohty D, Pradel S, Magne J, Fadel B, Boulogne C, Petitalot V, Raboukhi S, Darodes N, Damy T, Aboyans V, Jaccard A.Clin Res Cardiol 2017 Mayhttps://pubmed.ncbi.nlm.nih.gov/27933393/
27878441Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological studyPlanté-Bordeneuve V, Gorram F, Salhi H, Nordine T, Ayache SS, Le Corvoisier P, Azoulay D, Feray C, Damy T, Lefaucheur JP.J Neurol 2017 Febhttps://pubmed.ncbi.nlm.nih.gov/27878441/
27838303Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver TransplantationAlgalarrondo V, Antonini T, Théaudin M, Chemla D, Benmalek A, Lacroix C, Castaing D, Cauquil C, Dinanian S, Eliahou L, Samuel D, Adams D, Le Guludec D, Slama MS, Rouzet F.JACC Cardiovasc Imaging 2016 Dechttps://pubmed.ncbi.nlm.nih.gov/27838303/
27836786Non-vitamin K antagonist oral anticoagulants and heart failureIsnard R, Bauer F, Cohen-Solal A, Damy T, Donal E, Galinier M, Hagège A, Jourdain P, Leclercq C, Sabatier R, Trochu JN, Cohen A.Arch Cardiovasc Dis 2016 Novhttps://pubmed.ncbi.nlm.nih.gov/27836786/
27804073Early-phase myocardial uptake intensity of (99m)Tc-HMDP vs (99m)Tc-DPD in patients with hereditary transthyretin-related cardiac amyloidosisAbulizi M, Cottereau AS, Guellich A, Vandeventer S, Galat A, Van Der Gucht A, Plante-Bordeneuve V, Dubois-Randé JL, Bodez D, Rosso J, Damy T, Itti E.J Nucl Cardiol 2018 Febhttps://pubmed.ncbi.nlm.nih.gov/27804073/
27798053Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathyRosmini S, Biagini E, O’Mahony C, Bulluck H, Ruozi N, Lopes LR, Guttmann O, Reant P, Quarta CC, Pantazis A, Tome-Esteban M, Mckenna WJ, Rapezzi C, Elliott PM.Heart 2017 Feb 15https://pubmed.ncbi.nlm.nih.gov/27798053/
27692958Usefulness of T2 ratio in the diagnosis and prognosis of cardiac amyloidosis using cardiac MR imagingLegou F, Tacher V, Damy T, Planté-Bordeneuve V, Rappeneau S, Benhaiem N, Rosso J, Itti E, Luciani A, Kobeiter H, Rahmouni A, Deux JF.Diagn Interv Imaging 2017 Febhttps://pubmed.ncbi.nlm.nih.gov/27692958/
27647161Identification of prognostic markers in transthyretin and AL cardiac amyloidosisDamy T, Jaccard A, Guellich A, Lavergne D, Galat A, Deux JF, Hittinger L, Dupuis J, Frenkel V, Rigaud C, Plante-Bordeneuve V, Bodez D, Mohty D.Amyloid 2016 Sephttps://pubmed.ncbi.nlm.nih.gov/27647161/
27513652Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosisHamon D, Algalarrondo V, Gandjbakhch E, Extramiana F, Marijon E, Elbaz N, Selhane D, Dubois-Rande JL, Teiger E, Plante-Bordeneuve V, Damy T, Lellouche N.Int J Cardiol 2016 Nov 1https://pubmed.ncbi.nlm.nih.gov/27513652/
27492996Cardiac amyloidosis: How to recognize them and manage them?Bodez D, Galat A, Guellich A, Deux JF, Rosso J, Le Bras F, Funalot B, Fanen P, Benhaiem N, Planté-Bordeneuve V, Dubois-Randé JL, Lellouche N, Guendouz S, Molinier-Frenkel V, Mohty D, Damy T.Presse Med 2016 Octhttps://pubmed.ncbi.nlm.nih.gov/27492996/
27424245Early Phase (99)Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac AmyloidosisGalat A, Van der Gucht A, Guellich A, Bodez D, Cottereau AS, Guendouz S, Hittinger L, Dubois-Randé JL, Plante-Bordeneuve V, Itti E, Meignan M, Damy T, Rosso J.JACC Cardiovasc Imaging 2017 Mayhttps://pubmed.ncbi.nlm.nih.gov/27424245/
27386769Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B, Judge DP, Lenihan DJ, Gottlieb SS, Shah SJ, Steidley DE, Ventura H, Murali S, Silver MA, Jacoby D, Fedson S, Hummel SL, Kristen AV, Damy T, Planté-Bordeneuve V, Coelho T, Mundayat R, Suhr OB, Waddington Cruz M, Rapezzi CJ Am Coll Cardiol2016 Julhttps://pubmed.ncbi.nlm.nih.gov/27386769/
27371713One train may hide another: look beyond the aortic valve for cardiac amyloidosisVenner C, Busby-Venner H, Selton-Suty C, Huttin O.Eur Heart J 2016 Dec 14https://pubmed.ncbi.nlm.nih.gov/27371713/
27348696Prognostic value of right ventricular systolic function in cardiac amyloidosisBodez D, Ternacle J, Guellich A, Galat A, Lim P, Radu C, Guendouz S, Bergoend E, Couetil JP, Hittinger L, Dubois-Randé JL, Plante-Bordeneuve V, Deux JF, Mohty D, Damy T.Amyloid 2016 Sephttps://pubmed.ncbi.nlm.nih.gov/27348696/
27240600Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathyBennani Smires Y, Victor G, Ribes D, Berry M, Cognet T, Méjean S, Huart A, Roussel M, Petermann A, Roncalli J, Carrié D, Rousseau H, Berry I, Chauveau D, Galinier M, Lairez O.Int J Cardiovasc Imaging 2016 Sephttps://pubmed.ncbi.nlm.nih.gov/27240600/
27194782Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance studyMohty D, Boulogne C, Magne J, Varroud-Vial N, Martin S, Ettaif H, Fadel BM, Bridoux F, Aboyans V, Damy T, Jaccard A.Eur Heart J Cardiovasc Imaging 2016 Sephttps://pubmed.ncbi.nlm.nih.gov/27194782/
27143678Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisGillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN.Circulation 2016 Jun 14https://pubmed.ncbi.nlm.nih.gov/27143678/
27091529Prevalence, Severity, and Prognostic Value of Sleep Apnea Syndromes in Cardiac AmyloidosisBodez D, Guellich A, Kharoubi M, Covali-Noroc A, Tissot CM, Guendouz S, Hittinger L, Dubois-Randé JL, Lefaucheur JP, Planté-Bordeneuve V, Adnot S, Boyer L, Damy T.Sleep 2016 Jul 1https://pubmed.ncbi.nlm.nih.gov/27091529/
27002091Response to Letters Regarding Article, “Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis”Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, Maestrini V, Barcella W, Rosmini S, Bulluck H, Sayed RH, Patel K, Mamhood S, Bucciarelli-Ducci C, Whelan CJ, Herrey AS, Lachmann HJ, Wechalekar AD, Manisty CH, Schelbert EB, Kellman P, Gillmore JD, Hawkins PN, Moon JC.Circulation 2016 Mar 22https://pubmed.ncbi.nlm.nih.gov/27002091/
26908951Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?Galat A, Guellich A, Bodez D, Slama M, Dijos M, Zeitoun DM, Milleron O, Attias D, Dubois-Randé JL, Mohty D, Audureau E, Teiger E, Rosso J, Monin JL, Damy T.Eur Heart J 2016 Dec 14https://pubmed.ncbi.nlm.nih.gov/26908951/
26880259Multimodality Imaging of Cardiac Transthyretin Amyloidosis 16 Years After a Domino Liver TransplantationBechiri MY, Eliahou L, Rouzet F, Fouret PJ, Antonini T, Samuel D, Adam R, Adams D, Slama MS, Algalarrondo V.Am J Transplant 2016 Julhttps://pubmed.ncbi.nlm.nih.gov/26880259/
26870387Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathyDamy T, Maurer MS, Rapezzi C, Planté-Bordeneuve V, Karayal ON, Mundayat R, Suhr OB, Kristen AV.Open Heart 2016 Feb 8https://pubmed.ncbi.nlm.nih.gov/26870387/
26825321Cardiac amyloidosis: an unusual cause of low flow-low gradient aortic stenosis with preserved ejection fractionHaloui F, Salaun E, Maysou L, Dehaene A, Habib G.Eur Heart J Cardiovasc Imaging2016 Aprhttps://pubmed.ncbi.nlm.nih.gov/26825321/
26777222Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac AmyloidosisTernacle J, Bodez D, Guellich A, Audureau E, Rappeneau S, Lim P, Radu C, Guendouz S, Couetil JP, Benhaiem N, Hittinger L, Dubois-Randé JL, Plante-Bordeneuve V, Mohty D, Deux JF, Damy T.JACC Cardiovasc Imaging 2016 Febhttps://pubmed.ncbi.nlm.nih.gov/26777222/
26537620Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thicknessDamy T, Costes B, Hagège AA, Donal E, Eicher JC, Slama M, Guellich A, Rappeneau S, Gueffet JP, Logeart D, Planté-Bordeneuve V, Bouvaist H, Huttin O, Mulak G, Dubois-Randé JL, Goossens M, Canoui-Poitrine F, Buxbaum JN.Eur Heart J 2016 Jun 14https://pubmed.ncbi.nlm.nih.gov/26537620/
26516176Haematological determinants of cardiac involvement in adults with sickle cell diseaseDamy T, Bodez D, Habibi A, Guellich A, Rappeneau S, Inamo J, Guendouz S, Gellen-Dautremer J, Pissard S, Loric S, Wagner-Ballon O, Godeau B, Adnot S, Dubois-Randé JL, Hittinger L, Galactéros F, Bartolucci P.Eur Heart J 2016 Apr 7https://pubmed.ncbi.nlm.nih.gov/26516176/
26465835Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosisGalat A, Rosso J, Guellich A, Van Der Gucht A, Rappeneau S, Bodez D, Guendouz S, Tissot CM, Hittinger L, Dubois-Randé JL, Plante-Bordeneuve V, Itti E, Meignan M, Damy T.Amyloid2015https://pubmed.ncbi.nlm.nih.gov/26465835/
26403145[18F]-NaF PET/CT imaging in cardiac amyloidosisVan Der Gucht A, Galat A, Rosso J, Guellich A, Garot J, Bodez D, Plante-Bordeneuve V, Hittinger L, Dubois-Randé JL, Evangelista E, Sasanelli M, Chalaye J, Meignan M, Itti E, Damy T.J Nucl Cardiol 2016 Aughttps://pubmed.ncbi.nlm.nih.gov/26403145/
26362631Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac AmyloidosisFontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, Maestrini V, Barcella W, Rosmini S, Bulluck H, Sayed RH, Patel K, Mamhood S, Bucciarelli-Ducci C, Whelan CJ, Herrey AS, Lachmann HJ, Wechalekar AD, Manisty CH, Schelbert EB, Kellman P, Gillmore JD, Hawkins PN, Moon JC.Circulation 2015 Oct 20https://pubmed.ncbi.nlm.nih.gov/26362631/
26002815(99m)Tc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosisGalat A, Van Der Gucht A, Colombat M, Attias D, Itti E, Meignan M, Lebras F, Molinier-Frenkel V, Benhaiem N, Guellich A, Rosso J, Damy T.J Nucl Cardiol 2015 Aughttps://pubmed.ncbi.nlm.nih.gov/26002815/
25743445Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosisDamy T, Judge DP, Kristen AV, Berthet K, Li H, Aarts J.J Cardiovasc Transl Res 2015 Marhttps://pubmed.ncbi.nlm.nih.gov/25743445/
25693664Noninvasive detection of cardiac amyloidosis using delayed enhanced MDCT: a pilot studyDeux JF, Mihalache CI, Legou F, Damy T, Mayer J, Rappeneau S, Planté-Bordeneuve V, Luciani A, Kobeiter H, Rahmouni A.Eur Radiol 2015 Aughttps://pubmed.ncbi.nlm.nih.gov/25693664/
25416603Current and future treatment of amyloid neuropathiesAdams D, Cauquil C, Theaudin M, Rousseau A, Algalarrondo V, Slama MS.Expert Rev Neurother 2014 Dechttps://pubmed.ncbi.nlm.nih.gov/25416603/
25211144Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective studyDeux JF, Damy T, Rahmouni A, Mayer J, Planté-Bordeneuve V.Amyloid 2014 Dechttps://pubmed.ncbi.nlm.nih.gov/25211144/
25069833Familial amyloid polyneuropathy: elaboration of a therapeutic patient education programme, “EdAmyl”Théaudin M, Cauquil C, Antonini T, Algalarrondo V, Labeyrie C, Aycaguer S, Clément M, Kubezyk M, Nonnez G, Morier A, Bourges C, Darras A, Mouzat L, Adams D.Amyloid 2014 Dechttps://pubmed.ncbi.nlm.nih.gov/25069833/
24997877Answer to the letter from Mrs Aurélie Daumas about our article “senile systemic amyloidosis: definition, diagnosis, why thinking about?”Rosso J, Gallat A, Guellich A, Damy TPresse Med2014 Septhttps://pubmed.ncbi.nlm.nih.gov/24997877/
24482069FAP neuropathy and emerging treatmentsAdams D, Théaudin M, Cauquil C, Algalarrondo V, Slama M.Curr Neurol Neurosci Rep 2014 Marhttps://pubmed.ncbi.nlm.nih.gov/24482069/
24090573Cardiac amyloidosis: a case series of 14 patients, description and prognosisIsabel C, Georgin-Lavialle S, Aouba A, Delarue R, Nochy D, Karras A, Azarine A, Hermine O, Ranque B, Hagège A, Pouchot J.Rev Med Interne 2013 Novhttps://pubmed.ncbi.nlm.nih.gov/24090573/
24070600Cardiac amyloidosis: updates in diagnosis and managementMohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, Jaccard A.Arch Cardiovasc Dis 2013 Octhttps://pubmed.ncbi.nlm.nih.gov/24070600/
24070596Characterization of untyped cardiac amyloidosis by mass spectrometry in a patient with Gly6Ser transthyretin polymorphism in fatal cardiogenic shockDamy T, Plante-Bordeneuve V, Dogan A.Arch Cardiovasc Dis 2014 Dechttps://pubmed.ncbi.nlm.nih.gov/24070596/
23964755Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosisDamy T, Deux JF, Moutereau S, Guendouz S, Mohty D, Rappeneau S, Guellich A, Hittinger L, Loric S, Lefaucheur JP, Plante-Bordeneuve V.Amyloid 2013 Dechttps://pubmed.ncbi.nlm.nih.gov/23964755/
23669316[Senile systemic amyloidosis: definition, diagnosis, why thinking about?]Damy T, Mohty D, Deux JF, Rosso J, Benhaiem N, Lellouche N, Sabbah L, Guendouz S, Tissot CM, Rappeneau S, Pongas D, Bodez D, Krypciak S, Guellich A, Dubois-Randé JL, Hittinger L, Lefaucheur JP, Jaccard A, Planté-Bordeneuve V.Presse Med 2013 Junhttps://pubmed.ncbi.nlm.nih.gov/23669316/
23306657Neurophysiological markers of small fibre neuropathy in TTR-FAP mutation carriersLefaucheur JP, Ng Wing Tin S, Kerschen P, Damy T, Planté-Bordeneuve V.J Neurol 2013 Junhttps://pubmed.ncbi.nlm.nih.gov/23306657/
23177490Diagnosis of cardiac amyloidosis by magnetic resonance imaging due to a new mutation in the transthyretin geneDamy T, Plante-Bordeneuve V, Valleix S.Arch Cardiovasc Dis 2012 Novhttps://pubmed.ncbi.nlm.nih.gov/23177490/
22709469Circadian rhythm of blood pressure reflects the severity of cardiac impairment in familial amyloid polyneuropathyAlgalarrondo V, Eliahou L, Thierry I, Bouzeman A, Dasoveanu M, Sebag C, Moubarak G, Le Guludec D, Samuel D, Adams D, Dinanian S, Slama MS.Arch Cardiovasc Dis 2012 Mayhttps://pubmed.ncbi.nlm.nih.gov/22709469/
22387306Prophylactic pacemaker implantation in familial amyloid polyneuropathyAlgalarrondo V, Dinanian S, Juin C, Chemla D, Bennani SL, Sebag C, Planté V, Le Guludec D, Samuel D, Adams D, Slama MS.Heart Rhythm 2012 Julhttps://pubmed.ncbi.nlm.nih.gov/22387306/
20800158Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imagingMekinian A, Lions C, Leleu X, Duhamel A, Lamblin N, Coiteux V, De Groote P, Hatron PY, Facon T, Beregi JP, Hachulla E, Launay DAm J Med2010 Septhttps://pubmed.ncbi.nlm.nih.gov/20800158/
20142122Left ventricular hypertrophy: cardiac magnetic resonance may help differentiate amyloidosis from hypertrophic cardiomyopathyMabru M, Dacher JN, Bauer F.Arch Cardiovasc Dis 2010 Janhttps://pubmed.ncbi.nlm.nih.gov/20142122/
18579503Mitochondriopathy: a rare aetiology of restrictive cardiomyopathyThebault C, Ollivier R, Leurent G, Marcorelles P, Langella B, Donal E.Eur J Echocardiogr 2008 Novhttps://pubmed.ncbi.nlm.nih.gov/18579503/
16797793Original case report of amyloidosis with pleural involvement: the role of echocardiography in the diagnosisRoubille F, Billotet C, Roubille C.Rev Med Interne 2006 Octhttps://pubmed.ncbi.nlm.nih.gov/16797793/
Nos experts présentent les articles de l’actualité de manière interactive dans la Bibli’OSE : la bibliographie de l’amylose. 
Vous pouvez assister aux live. Un jeudi sur deux de 13h30 à 14h00 : www.bibliose.org
Les replays de ces émissions sont également disponibles sur cette même plateforme et sur notre chaine YouTube CLIQUEZ ICI.